Value Dossiers & Value Assessment in France, UK and Germany
29.04.2014 16:31
Harmonised value assessment in Europe - utopia or already in progress?
Drug value assessment/HTA is an important payer's tool in many European countries. This meeting focuses on the assessment systems in the UK, France and Germany and addresses the international projects heading towards a more harmonised value assessment in Europe.
Termindetails
Wann
15.09.2014
von 09:00 bis 17:00
von 09:00 bis 17:00
Wo
Berlin
Kontakttelefon
+49 6221 500-680
Teilnehmer
This meeting addresses the needs of managing directors and co-workers in the pharmaceutical industry who are involved in market access and healthcare management. Especially those who are responsible for the international business will beneft from this meeting.
Drug value assessment/HTA is an important payer's tool in many European countries. This meeting focuses on the assessment systems in the UK, France and Germany and addresses the international projects heading towards a more harmonised value assessment in Europe.
After having attended this meeting you will be aware of the current status and the challenges for the national systems in the UK, France and Germany, and have a sound perspective on what you can expect from the European HTA cooperations.
topics:
- Harmonised value assessment in Europe - utopia or already in progress?
- Practical aspects of the cooperation between HTA bodies
- Drug assessment by the French HAS
- Value dossiers for Germany / the EU
- Value dossiers in the UK
